My Health News » Cancer

Feeds

164867 items (164867 unread) in 46 feeds

World Health Organization (462 unread)

• WHO news (251 unread)
• Disease Outbreak News (211 unread)

Media (128004 unread)

• Reuters Health eLine (5187 unread)
• CNN Health (1931 unread)
• NPR Health and Science (2586 unread)
• ABC News: Health (3885 unread)
• CBSnews.com: Health News (4511 unread)
• BBC Health News (3762 unread)
• CBC Health and Science News (3016 unread)
• Australia ABC News: Health (7721 unread)
• China Xinghua Health News (3974 unread)
• New York Times: Health (8872 unread)
• USATODAY.com Health - Top Stories (2939 unread)
• The Seattle Times: Health (2304 unread)
• International Herald Tribune: Health and Science (1983 unread)
• HeraldToday.com: Health (1832 unread)
• WebMD Health Headlines (4443 unread)
• MedicineNet Daily News (7011 unread)
• Medical News Today (39030 unread)
• iVillage Health (956 unread)
• Topix.net - Health (3398 unread)
• Newsvine - health (18663 unread)

Bird Flu (3515 unread)

• MSNBC.com: Bird Flu (143 unread)
• Topix.net - Bird Flu (2287 unread)
• Medical News Today - Bird Flu/Avian Flu (580 unread)
• MedicineNet Cold and Flu General (505 unread)

Diabetes (5648 unread)

• Topix.net - Diabetes (3040 unread)
• Medical News Today - Diabetes (1930 unread)
• MedicineNet Diabetes General (678 unread)

Cholesterol (2462 unread)

• Topix.net - Cholesterol (1117 unread)
• Medical News Today - Cholesterol (396 unread)
• MedicineNet Cholesterol General (949 unread)

Cancer (11808 unread)

• MSNBC.com: Cancer (527 unread)
• Topix.net - Cancer (2963 unread)
• Medical News Today - Breast Cancer News (1539 unread)
• Medical News Today - Cancer/Oncology News (5215 unread)
• MedicineNet Cancer General (1564 unread)

HIV (7247 unread)

• Topix.net - HIV/AIDS (2662 unread)
• Medical News Today - HIV/AIDS News (4342 unread)
• MedicineNet HIV General (243 unread)

Women (4402 unread)

• MSNBC.com: Women's Health (328 unread)
• Medical News Today - OBGYN News (2812 unread)
• MedicineNet Womens Health General (1262 unread)

Men (1319 unread)

• MSNBC.com: Men's Health (136 unread)
• Medical News Today - Men's health News (529 unread)
• MedicineNet Mens Health General (654 unread)

Cancer (100 unread)

Topix.net - Cancer

• Cancer lottery: Why the odds are still stacked against the poor

  Posted: September 7th, 2008, 5:09am EDT

  Professor Karol Sikora said people from wealthier areas were fast tracked for treatment because they pushed for it harder Cancer patients living in richer areas are significantly more likely to survive, ...

Medical News Today - Breast Cancer News

• Study Suggests A Possible Way To Offset Chemobrain Memory Loss

  Posted: September 7th, 2008, 3:00am EDT

  Cancer patients have complained for years about the mental fog known as chemobrain. Now in animal studies at West Virginia University (WVU), researchers have discovered that injections of N-acetyl cysteine (NAC), an antioxidant, can prevent the memory loss that breast cancer chemotherapy drugs sometimes induce. The WVU researchers' study has just been published in the September issue of the Springer journal Metabolic Brain Disease.

Medical News Today - Cancer/Oncology News

• Early And Accurate Detection Of Bowel Cancer With RanplexCRC - Detects 28 Polymorphisms Associated With Colorectal Cancer In A Single Stool Sample

  Posted: September 7th, 2008, 3:00am EDT

  RanplexCRC is a diagnostic test that can detect 28 polymorphisms associated with colorectal cancer in a single stool sample. It does not require a hospital visit or dietary restrictions, while having greater sensitivity than the currently used Faecal Occult Blood (FOB) screening test. RanplexCRC may more accurately profile patients and reduce the number of patients for colonoscopy, saving time and resources and reducing patient discomfort.

• An Advance On New Generations Of Chemotherapy And Antiviral Drugs

  Posted: September 7th, 2008, 3:00am EDT

  Researchers are describing progress toward developing a new generation of chemotherapy agents that target and block uncontrolled DNA replication - a hallmark of cancer, viral infections, and other diseases - more effectively than current drugs in ways that may produce fewer side effects. Their article is scheduled for the Aug. 27 issue of ACS' Biochemistry, a weekly journal. In the article, Anthony J.

• Study Suggests A Possible Way To Offset Chemobrain Memory Loss

  Posted: September 7th, 2008, 3:00am EDT

  Cancer patients have complained for years about the mental fog known as chemobrain. Now in animal studies at West Virginia University (WVU), researchers have discovered that injections of N-acetyl cysteine (NAC), an antioxidant, can prevent the memory loss that breast cancer chemotherapy drugs sometimes induce. The WVU researchers' study has just been published in the September issue of the Springer journal Metabolic Brain Disease.

Topix.net - Cancer

• Breast MRIs delay cancer treatment by weeks: study

  Posted: September 7th, 2008, 12:53am EDT

  Women with newly diagnosed breast cancer who get an MRI scan wait about three weeks longer before their surgery and are far more likely to get a mastectomy than women who have only a mammogram, U.S. researchers ...

• Robert Novak column describes brain cancer treatment

  Posted: September 6th, 2008, 8:23pm EDT

  Conservative political commentator Robert Novak says he's lost partial vision and undergone a lengthy surgery to remove a tumor since being diagnosed with brain cancer.

• Biogen to test Tysabri as a cancer treatment

  Posted: September 6th, 2008, 3:48pm EDT

  Biogen Idec has begun testing the multiple sclerosis drug Tysabri as a treatment for blood cancer.

• Treatment of cancer gets boost with a failed drug

  Posted: September 6th, 2008, 11:29am EDT

  Unsatisfying drug for anxiety reveals scientists a promising novel anti-cancer drug target opening a new door for cancer treatment.

Medical News Today - Cancer/Oncology News

• First Day Of Ovarian Cancer Symposium Focuses On Early Detection - Ovarian Cancer Research Symposium

  Posted: September 6th, 2008, 10:00am EDT

  Leading ovarian cancer researchers and clinicians from around the world gathered at the Ovarian Cancer Research Symposium today to hear about cutting-edge developments that may increase the chances of early detection of the disease. Dr. Patricia Kruk, from the University of South Florida, presented her research that could lead to using a non-invasive urine test for detecting ovarian cancer.

• Elan And Biogen Idec Initiate First Clinical Trial Of TYSABRI(R) In Oncology - First Multiple Myeloma Patient Treated

  Posted: September 6th, 2008, 8:00am EDT

  Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) announced the initiation of the first clinical trial of TYSABRI® (natalizumab) in oncology. The first dose of TYSABRI was administered yesterday in the trial. The objectives of this Phase I/II study are to evaluate the safety and potential anti-tumor activity of TYSABRI in patients with relapsed or refractory multiple myeloma.

Topix.net - Cancer

• Parsing the genome of a deadly brain tumor

  Posted: September 6th, 2008, 7:06am EDT

  The most comprehensive to-date genomic analysis of a cancer - the deadly brain tumor glioblastoma multiforme - shows previously unrecognized changes in genes and provides an overall view of the missteps in the ...

Medical News Today - Cancer/Oncology News

• Amrubicin Receives FDA Fast Track Designation For The Treatment Of Small Cell Lung Cancer After First-Line Chemotherapy

  Posted: September 6th, 2008, 5:00am EDT

  Celgene Corporation (NASDAQ: CELG) announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.

• After A Liver Operation, African-Americans At Twice The Risk Of Death As Caucasians

  Posted: September 6th, 2008, 4:00am EDT

  New research published in the Journal of the American College of Surgeons shows African Americans are more than twice as likely as Caucasians to die in the hospital after surgical removal of part of the liver -- an increasingly used procedure for the treatment of liver cancer. In recent years, a large body of evidence has emerged revealing significant racial disparities in health care and outcomes in the United States.

• Atomic Structure Of The Mammalian "fatty Acid Factory" Determined

  Posted: September 6th, 2008, 4:00am EDT

  Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is also a promising target for the development of anti-cancer and anti-obesity drugs and the treatment of metabolic disorders. Now researchers at ETH Zurich have determined the atomic structure of a mammalian fatty acid synthase. Their results have just been published in Science magazine.

• Unsuccessful Drug Against Anxiety Opens A Novel Gateway For The Treatment Of Cancer

  Posted: September 6th, 2008, 4:00am EDT

  Cancer cells have multiple ways to avoid apoptosis, programmed cell death the means by which organisms deal with defective cells. One defense is to produce quantities of phosphatic acid, a phospholipid constituent of cellular membranes. Unlike other phospholipids, phosphatidic acid also acts as a signaling molecule for cells promoting cellular growth and preventing apoptosis.

• Rosetta Genomics Identifies Potential MicroRNA Biomarkers In Blood Serum

  Posted: September 6th, 2008, 4:00am EDT

  Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic products, announced that the results of a study conducted by its scientists describing the identification of microRNA biomarkers in blood serum, have been published online in the peer-reviewed journal PLOS One. The findings demonstrate that microRNAs have the potential to be used as clinical biomarkers for a wide range of indications in cancer and women's health.

• Pennsylvania Secretary Of Health Stresses Importance Of Cancer Awareness, Education

  Posted: September 6th, 2008, 4:00am EDT

  With the "Stand Up to Cancer" national telethon airing tonight, Secretary of Health Dr. Calvin B. Johnson is reminding Pennsylvanians to educate themselves about cancer and the resources available through the Department of Health. The telethon, aimed at increasing cancer awareness and raising money to support life-saving research, will be carried by the ABC, CBS and NBC networks.

• Vulvar Cancer: A Hidden Disease

  Posted: September 6th, 2008, 4:00am EDT

  Vulvar cancer is the fourth most common cancer of the female genital tract. In 2008, roughly 3,460 cases of vulvar cancer will be diagnosed in the United States and about 870 will die of this cancer, according to the American Cancer Society. There are several different types of vulvar cancer. More than 90 percent are squamous cell carcinomas. Squamous cells are the same kind of cells that comprise most of the skin on the body and the cells that line the inside the body's cavities.

• 25 Years Of Conventional Evaluation Of Data Analysis Proves Worthless In Practice

  Posted: September 6th, 2008, 3:00am EDT

  So-called 'intelligent' computer-based methods for classifying patient samples, for example, have been evaluated with the help of two methods that have completely dominated research for 25 years. Now Swedish researchers at Uppsala University are revealing that this methodology is worthless when it comes to practical problems. The article is published in the journal Pattern Recognition Letters.

• Novel Gateway For The Treatment Of Cancer Opened By Unsuccessful Anxiety Drug

  Posted: September 6th, 2008, 3:00am EDT

  Cancer cells have multiple ways to avoid apoptosis, programmed cell death the means by which organisms deal with defective cells. One defense is to produce quantities of phosphatic acid, a phospholipid constituent of cellular membranes. Unlike other phospholipids, phosphatidic acid also acts as a signaling molecule for cells promoting cellular growth and preventing apoptosis.

• Improved Understanding Of Kidney Diseases

  Posted: September 6th, 2008, 3:00am EDT

  By introducing a genetic switch in mice it is possible to increase or decrease the production of specific protein molecules in their kidneys. Thus, researchers can study the influence of specific proteins on disease development. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg University Hospitals and other research institutes have published this model of investigating severe kidney diseases in the latest issue of Nature Medicine.

• More Comprehensive Portrait Of Brain Cancer As A Result Of Collaboration Between Researchers

  Posted: September 6th, 2008, 3:00am EDT

  A team including researchers at the HudsonAlpha Institute and Stanford University, together with colleagues from a number of other organizations, has published a comprehensive analysis of genomic variation in the brain cancer glioblastoma. These results are the first from the Cancer Genome Atlas (TCGA) research network, a collaborative effort funded by the National Cancer Institute and the National Human Genome Research Institute of the National Institutes of Health.

• Discovery of Potential New Targets In Brain Tumors Following Massive Cancer Gene Search

  Posted: September 6th, 2008, 3:00am EDT

  An array of broken, missing, and overactive genes -- some implicated for the first time -- have been identified in a genetic survey of glioblastoma, the most common and deadly form of adult brain cancer, report scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard, together with their collaborating investigators at 18 institutions and organizations.

• Numerous Undiscovered Gene Alterations In Pancreatic And Brain Cancers Revealed

  Posted: September 6th, 2008, 3:00am EDT

  HHMI investigators have detected a multitude of broken, missing, and overactive genes in pancreatic and brain tumors, in the most detailed genetic survey yet of any human tumor. Some of these genetic changes were previously unknown and could provide new leads for improved diagnosis and therapy for these devastating cancers.

Topix.net - Cancer

• African-Americans have unique lung cancer risks

  Posted: September 6th, 2008, 2:53am EDT

  Scientists at the M.D. Anderson Cancer Center have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary ...

• Discovery Challenges Fundamental Tenet Of Cancer Biology

  Posted: September 5th, 2008, 10:29pm EDT

  The discovery that these rearranged products exist in normal as well as cancerous cells potentially complicates the diagnosis of some cancers and raises the possibility that anti-cancer drugs like Gleevec could ...

Medical News Today - Cancer/Oncology News

• Goshen Center For Cancer Care Doctor Named Naturopathic Physician Of The Year

  Posted: September 5th, 2008, 7:00pm EDT

  Goshen Center for Cancer Care's Director of Integrated Care, Marcia Prenguber, ND, FABNO, has been chosen as the 2008 Naturopathic Physician of the Year by the American Association of Naturopathic Physicians. Dr. Prenguber was honored, and presented with the award, during the AANP's 2008 Annual Convention & Exposition on Aug, 16 at the Arizona Biltmore Resort & Spa in Phoenix, Ariz.

Topix.net - Cancer

• Drug Re-Sensitizes Breast Tumors to Treatment

  Posted: September 5th, 2008, 6:09pm EDT

  The drug sorafenib may help "re-sensitize" certain breast cancer tumors to anti-hormonal drugs, Georgetown University Medical Center researchers say.

Medical News Today - Cancer/Oncology News

• Discovery Challenges Fundamental Tenet Of Cancer Biology

  Posted: September 5th, 2008, 4:00pm EDT

  Yale researchers have identified an unusual molecular process in normal tissues that causes RNA molecules produced from separate genes to be clipped and stitched together. The discovery that these rearranged products exist in normal as well as cancerous cells potentially complicates the diagnosis of some cancers and raises the possibility that anti-cancer drugs like Gleevec could have predictable side effects. The work is reported in the journal Science.

Topix.net - Cancer

• Health Tip: Getting Ready for Cancer Treatment

  Posted: September 5th, 2008, 1:50pm EDT

  Treatment for cancer takes an emotional and physical toll on your body. But you can take steps to prepare for the treatment that will help make the process easier.

Medical News Today - Cancer/Oncology News

• Scientists Map Complete Genetic Blueprint Of Deadly Cancers

  Posted: September 5th, 2008, 1:00pm EDT

  In what has been heralded as a significant breakthrough in the fight against two of the world's deadliest cancers, US scientists have mapped complete genetic blueprints comprising more than 20,000 genes in 24 pancreatic cancers and 22 brain cancers, including not only individual gene mutations but also their interlinked pathways which sustain tumour development and growth.

Medical News Today - Breast Cancer News

• OncoMune Publishes Positive Results Of OCM-8054 - Breast Cancer Dependency On BORIS Unequivocally Demonstrated By RNA Interference

  Posted: September 5th, 2008, 12:00pm EDT

  OncoMune LLC, a biotechnology company focused on developing targeted cancer therapeutics, announced the publication of its preclinical OCM-8054 data. The publication entitled, "Selective apoptosis of breast cancer cells by siRNA targeting of BORIS," appeared in the May 23rd 2008 issue of the scientific journal, Biochemical and Biophysical Research Communications, Volume 370, Issue 1, Pages 109-112.

Medical News Today - Cancer/Oncology News

• OncoMune Publishes Positive Results Of OCM-8054 - Breast Cancer Dependency On BORIS Unequivocally Demonstrated By RNA Interference

  Posted: September 5th, 2008, 12:00pm EDT

  OncoMune LLC, a biotechnology company focused on developing targeted cancer therapeutics, announced the publication of its preclinical OCM-8054 data. The publication entitled, "Selective apoptosis of breast cancer cells by siRNA targeting of BORIS," appeared in the May 23rd 2008 issue of the scientific journal, Biochemical and Biophysical Research Communications, Volume 370, Issue 1, Pages 109-112.

Medical News Today - Breast Cancer News

• Black Women Less Likely Than White Women To Receive Follow-Up Treatments After Breast Cancer Surgery, Study Finds

  Posted: September 5th, 2008, 11:00am EDT

  Black women who undergo a lumpectomy surgery to treat early-stage breast cancer are less likely than their white counterparts to receive the recommended follow-up radiation therapy treatments, according to study released on Wednesday, Reuters/Boston Globe reports.

Topix.net - Cancer

• Networks join forces for special on cancer

  Posted: September 5th, 2008, 9:40am EDT

  Katie Couric, Charles Gibson and Brian Williams have something in common besides their jobs: Each has lost loved ones to cancer -- which gives them something in common with almost everybody.

Medical News Today - Cancer/Oncology News

• HIV And Prostate Cancer: A Systematic Review Of The Literature

  Posted: September 5th, 2008, 9:00am EDT

  UroToday.com - In the online edition of Prostate Cancer Prostatic Diseases, Dr. Jonathan Silberstein and his colleagues presented a systematic review of HIV and prostate cancer (CaP). The message that may be underappreciated by the urology community is the excellent longevity of HIV patients, which clearly impacts their potential for diagnosis and management of CaP. In 2003, over one-million people were living with HIV in the US and three quarters of them were men.

MSNBC.com: Cancer

• The dangers of three quiet cancers

  Posted: September 5th, 2008, 8:15am EDT

  Mouth sores, unexplained fevers or joint pain, or discomfort during sex can be symptoms of three cancers — oral, leukemia, and endometrial — that don't get the attention they deserve.

  
  

Medical News Today - Breast Cancer News

• Agendia Launches TargetPrint(R) For Breast Cancer Patients

  Posted: September 5th, 2008, 7:00am EDT

  Agendia, a world leader in molecular cancer diagnostics, announced the launch of TargetPrint(R), a new diagnostic test that allows physicians to quantitatively determine the gene expression levels of the estrogen receptor (ER), progesterone receptor (PR) and Human Epidermal growth factor Receptor 2 (HER2) in breast cancer tumor biopsies.

• Blacks Less Likely Than Whites To Receive Standard Of Care In Radiation Therapy For Breast Cancer

  Posted: September 5th, 2008, 7:00am EDT

  Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center. The study, the largest of its kind, was presented in advance of the American Society of Clinical Oncology (ASCO) Breast Cancer Symposium, and is the first national study to examine such racial disparities in radiation therapy.

• Change In HER2 Status After Treatment With Herceptin Discovered By M. D. Anderson Study

  Posted: September 5th, 2008, 7:00am EDT

  Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs of disease at the time of surgery. However, of those women who had residual disease, about one-third had tumors that converted from HER2 positive to HER 2 negative status -possibly indicating a resistance to the targeted therapy.

Medical News Today - Cancer/Oncology News

• September 13th Is National Childhood Cancer Awareness Day

  Posted: September 5th, 2008, 7:00am EDT

  A pediatric bone cancer survivor who now is studying to become a pediatric hematologist/oncologist…a childhood leukemia survivor who has walked a mile in the shoes of the young cancer patients she now treats. These are just a few of the hundreds of patients treated through the Pediatric Hematology/Oncology program at The Cancer Institute of New Jersey (CINJ), which is celebrating 15 years of patient care this year.

• Scientists 'Stand Up To Cancer' With Latest Research

  Posted: September 5th, 2008, 7:00am EDT

  As the Stand Up To Cancer campaign -- being put forth by television's "Big 3" networks -- is opening the nation's eyes to the need and the benefit of cancer research dollars, The Cancer Institute of New Jersey (CINJ) is highlighting some of its groundbreaking studies being conducted by internationally recognized clinical investigators.

• Medarex Announces Presentations At The 33rd Congress Of The European Society For Medical Oncology

  Posted: September 5th, 2008, 6:00am EDT

  Medarex, Inc. (Nasdaq: MEDX) announced that nine clinical abstracts for ipilimumab, an investigational anti-CTLA-4 antibody, in melanoma are scheduled to be the subject of presentations at the 33rd Congress of the European Society for Medical Oncology (ESMO) being held September 12-16, 2008 in Stockholm.

• Azaya Therapeutics Licenses Promising Treatment For Head And Neck Cancers

  Posted: September 5th, 2008, 6:00am EDT

  Azaya Therapeutics, Inc., announced that it has signed a licensing agreement to further develop a breakthrough technology that uses liposomes to deliver radiation through direct injection into head and neck tumors, shrinking the tumor, delaying recurrence and avoiding the collateral tissue damage that often accompanies all other forms of radiation therapy. The company plans to begin a phase I clinical trial in early 2010.

Topix.net - Cancer

• Battle Against Cancer Being Fought in Topeka

  Posted: September 5th, 2008, 5:29am EDT

  The future of cancer treatment could lie among rows of files tucked in a room labelled "Research" at the Cotton-O'Neil Cancer Center.

Medical News Today - Cancer/Oncology News

• Nanoscale Droplets With Cancer-Fighting Implications Produced By Scientists

  Posted: September 5th, 2008, 5:00am EDT

  UCLA scientists have succeeded in making unique nanoscale droplets that are much smaller than a human cell and can potentially be used to deliver pharmaceuticals. "What we found that was unexpected was within each oil droplet there was also a water droplet - a double emulsion," said Timothy Deming, professor and chair of the UCLA Department of Bioengineering and a member of both the California NanoSystems Institute (CNSI) at UCLA and UCLA's Jonsson Cancer Center.

• Blood 'Fingerprints' For Cancer

  Posted: September 5th, 2008, 5:00am EDT

  Serum microRNAs (miRNAs) can serve as biomarkers for the detection of diseases including cancer and diabetes, according to research published online this week in Cell Research. The findings pave the way for a revolutionary non-invasive diagnostic tool. miRNAs are a class of naturally occurring small non-coding RNAs that have been linked with cancer development.

• Evident™ Microwave Ablation System Offers Surgical Oncologists And Interventional Radiologists Fast, Efficient Tool To Ablate Soft Tissue

  Posted: September 5th, 2008, 5:00am EDT

  Covidien (NYSE: COV, BSX: COV), a world leader in advanced energy-based surgical systems, today announced the global release of the Evident™ microwave ablation system. Physicians now have a powerful new tool with industry-leading technology to ablate soft tissue. The Evident™ microwave ablation system received 510(k) clearance from the United States Food and Drug Administration for use in soft tissue, and is now the first microwave ablation system available globally.

• News From CA: Cancer Quality Alliance, Blueprint For A Better Cancer Care System

  Posted: September 5th, 2008, 4:00am EDT

  Cancer Quality Alliance: Blueprint for a Better Cancer Care System In this report, the Cancer Quality Alliance (CQA), a national alliance advocating for improvements in the quality of cancer care in America, presents a set of 5 case studies that depict a vision of quality cancer care and a "Blueprint" for actions to realize this vision.

• Testosterone Administration To Men With Testosterone Deficiency Syndrome After External Beam Radiotherapy For Localized Prostate Cancer

  Posted: September 5th, 2008, 4:00am EDT

  UroToday.com - Dr. Alvaro Morales and associates from the Centre for Applied Urological Research, reported on the first study on testosterone deficiency syndrome (TDS) in men treated with radiotherapy for prostate cancer. Five men with clinically localized CaP were prospectively studied. The mean Gleason sum was 7 and mean PSA level before radiotherapy was 12.8ng/ml. The mean PSA before testosterone replacement therapy (TRT) was 0.3ng/ml.

• Cytopia Commences Second Phase II Study In Brain Cancer

  Posted: September 5th, 2008, 3:00am EDT

  Cytopia Limited (ASX:CYT) announced that it is commencing enrolment for its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, in patients with an aggressive form of brain cancer known as glioblastoma multiforme (GBM). The GBM clinical trial is the first Phase II efficacy study in highly vascular, solid tumour indications for the company and the second in its suite of Phase II studies designed to investigate the anti-cancer activity of CYT997.

• Research Questions Inequality Of Skin Cancer Monitoring For Transplant Patients

  Posted: September 5th, 2008, 3:00am EDT

  Kidney transplant patients, one of the most at-risk groups for skin cancer, are not being sufficiently educated or monitored for the disease, according to new research. Kidney transplant recipients are three times more likely to develop skin cancer than people who have not received a transplant. 30 percent of UK renal (kidney) transplant recipients (RTRs) will go on to develop non-melanoma skin cancer, the most common type, within 10 years.

• International Team Reveals First Prognosticator Of Survival In Aggressive Cancer

  Posted: September 5th, 2008, 3:00am EDT

  The tumor suppressor gene pRb2/p130 may provide the first independent prognostic biomarker in cases of soft tissue sarcoma (STS), according to an international collaboration of researchers, including scientists at the Sbarro Institute for Cancer Research and Molecular Medicine at the College of

• Few Parents Fear Cervical Cancer Jab Causes Promiscuity In Teens

  Posted: September 5th, 2008, 3:00am EDT

  Few parents worry that vaccinating their daughters against human papillomavirus (HPV) and cervical cancer would cause promiscuity. This is the finding of Dr Noel Brewer and colleagues from the University of North Carolina, USA and the Centers for Disease Control who will present their findings on Tuesday 9 September 2008 at the British Psychological Society's Division of Health Psychology's Annual Conference being held at the University of Bath.

• Bladder Tumor Markers: From Hematuria To Molecular Diagnostics - Where Do We Stand?

  Posted: September 5th, 2008, 3:00am EDT

  UroToday.com - Bladder cancer is an extremely lethal disease occurring in a large number of patients each year. Most evaluations that result in the diagnosis of bladder cancer are initiated with the finding of either gross or microscopic hematuria. While the majority of patients with hematuria will not have bladder cancer, a sizeable proportion will.

MedicineNet Cancer General

• Genetic Mutations Linked to Deadly Cancers

  Posted: September 5th, 2008, 3:00am EDT

  Title: Genetic Mutations Linked to Deadly Cancers
  Category: Health News
  Created: 9/5/2008 2:00:00 AM
  Last Editorial Review: 9/5/2008

• Tobacco-Tied Cancer Cases Top 2 Million

  Posted: September 5th, 2008, 3:00am EDT

  Title: Tobacco-Tied Cancer Cases Top 2 Million
  Category: Health News
  Created: 9/5/2008
  Last Editorial Review: 9/5/2008

• Deaths Heighten Arthritis Drugs Warning

  Posted: September 5th, 2008, 3:00am EDT

  Title: Deaths Heighten Arthritis Drugs Warning
  Category: Health News
  Created: 9/5/2008
  Last Editorial Review: 9/5/2008

Topix.net - Cancer

• Breast cancer support group to hold summit

  Posted: September 5th, 2008, 1:16am EDT

  A local breast cancer advocacy group will hold a Sept. 16 summit in Wausau to help identify survivors' needs.

• Antisoma Starts Phase II Trial of AS1411 in Renal Cancer

  Posted: September 4th, 2008, 9:01pm EDT

  Cancer drug developer Antisoma plc today announced that it has started a phase II study of AS1411 in metastatic renal cell carcinoma .

Medical News Today - Cancer/Oncology News

• WHO Proposes Strategy For Prevention And Control Of Cancer In The African Region

  Posted: September 4th, 2008, 7:00pm EDT

  The World Health Organization (WHO) has proposed a strategy to prevent and control cancer, 582 000 cases of which were recorded in the Region in 2002. Cancer of the cervix, breast, liver and prostate as well as Kaposi's sarcoma and non-Hodgkin's lymphoma are the most common forms of cancer in the African Region. Incidence of these cancers are projected to double by 2020 if effective interventions are not intensified.

Topix.net - Cancer

• PET Scans Yield Valuable Information In Treatment Of Colorectal Cancer

  Posted: September 4th, 2008, 4:48pm EDT

  Main Category: MRI / PET / Ultrasound Also Included In: Medical Devices / Diagnostics An article published in the September issue of The Journal of Nuclear Medicine finds that over 50% of colorectal cancer ...

MSNBC.com: Cancer

• Gene map shows no two cancers alike

  Posted: September 4th, 2008, 4:38pm EDT

  U.S. scientists have mapped the cascade of genetic changes that turn normal cells in the brain and pancreas into two of the most lethal cancers.

Medical News Today - Cancer/Oncology News

• Cellvizio(R) Imaging System Improves Bile Duct Cancer Detection According To A New Study In Clinical Gastroenterology And Hepatology

  Posted: September 4th, 2008, 2:00pm EDT

  A new imaging system that allows physicians to examine tissue at the cellular level from inside the body may now enable them to more effectively diagnose cancer of the bile ducts, according to a new study in the September 2008 issue of the journal Clinical Gastroenterology and Hepatology. This cancer, medically known as cholangiocarcinoma, is one of the most difficult to detect and treat.

Topix.net - Cancer

• Cancer Trials Struggle For Patients, Funds

  Posted: September 4th, 2008, 12:17pm EDT

  The medical community in places such as Boston is busy working on hundreds of clinical trials -- each one holding the promise of changing the future of cancer treatment.

Medical News Today - Breast Cancer News

• Wall Street Journal Examines Growing Fear Of Breast Cancer Among Some Young Girls

  Posted: September 4th, 2008, 11:00am EDT

  The Wall Street Journal on Tuesday examined the growing fear of breast cancer among some young girls that in part is because of information about the disease from the media. Marisa Weiss -- director of breast radiation oncology at Lankenau Hospital in Pennsylvania, founder of Breastcancer.

Topix.net - Cancer

• High Court Battle For Cancer Drugs

  Posted: September 4th, 2008, 7:57am EDT

  A cancer sufferer with two months to live is in a High Court battle to get drugs that could extend his life by three years.

Medical News Today - Cancer/Oncology News

• New Reporting From IntrinsiQ Measures Impact Of Key Events On Oncology Drug Usage

  Posted: September 4th, 2008, 7:00am EDT

  IntrinsiQ, LLC, the expert source for clinical oncology insight, launched Event IntelliView, a new analysis tool that quantifies the real-world impact of key events in the lifecycle of medical oncology drugs. Pharmaceutical research teams can now quickly make sense of vast amounts of product performance data, and see how activities like reporting on clinical findings, regulatory approvals and price changes positively or negatively impact market penetration.

Medical News Today - Breast Cancer News

• Olivia Newton-John Partners With Curves To Distribute The Liv(R) Breast Self-Exam Aid To 1 Million Women

  Posted: September 4th, 2008, 6:00am EDT

  Four-time Grammy winner Olivia Newton-John announces a partnership with Curves, the world's largest fitness franchise for women to launch an international campaign to distribute 1 million units of the Liv® Aid, a breast self-exam aid that assists women to exercise breast self-exams correctly.

Medical News Today - Cancer/Oncology News

• Clinical Trial Protocol Against Cancer Therapy Side Effects (Mucositis) Approved

  Posted: September 4th, 2008, 5:00am EDT

  Anadis Ltd. (ASX:ANX; OTC:ANDIY) an Australian biopharmaceutical company specializing in oral immunotherapy using naturally derived antibodies and other proteins is announcing the clinical protocol for its Cancer-related Mucositis Program was cleared by the Tel Aviv Souraski Medical Center's Institutional Review Board (IRB) and by the Israeli Ministry of Health (MOH). This enables the initiation of the clinical trial addressing this significant target at the medical center within a month.

Topix.net - Cancer

• Racial disparities seen in U.S. breast cancer care

  Posted: September 4th, 2008, 3:35am EDT

  By Will Dunham

  WASHINGTON (Reuters) - Doctors are less likely to give black women radiation therapy after surgery to remove early-stage breast cancer than white women, researchers said on Wednesday, adding to evidence of racial disparities in U.S. medicine.

  The 37,305 women 65 and older examined in the study had undergone a procedure called a lumpectomy in which doctors removed just the tumor and spared the breast, a procedure less radical than a mastectomy, which removes the entire breast.

Medical News Today - Cancer/Oncology News

• Height Linked To Risk Of Prostate Cancer Development And Progression

  Posted: September 4th, 2008, 3:00am EDT

  A man's height is a modest marker for risk of prostate cancer development, but is more strongly linked to progression of the cancer, say British researchers who conducted their own study on the connection and also reviewed 58 published studies. In the September issue of

• Human Genome Sciences Reports Initial Results Of Randomized Phase 2 Trial Of HGS-ETR1 In Combination With Bortezomib In Advanced Multiple Myeloma

  Posted: September 4th, 2008, 3:00am EDT

  Human Genome Sciences, Inc. (Nasdaq: HGSI) reported initial topline results from an ongoing randomized Phase 2 clinical trial of its TRAIL receptor antibody HGS-ETR1 (mapatumumab) in combination with bortezomib (Velcade) in patients with advanced multiple myeloma. The initial data from the multiple myeloma study show that HGS-ETR1 was well tolerated and suggest that disease response was comparable for this combination vs. bortezomib alone.

MedicineNet Cancer General

• New Drug Helps Relieve Gout

  Posted: September 4th, 2008, 3:00am EDT

  Title: New Drug Helps Relieve Gout
  Category: Health News
  Created: 9/4/2008 2:00:00 AM
  Last Editorial Review: 9/4/2008

• Study Links Serum Calcium, Prostate Cancer Death

  Posted: September 4th, 2008, 3:00am EDT

  Title: Study Links Serum Calcium, Prostate Cancer Death
  Category: Health News
  Created: 9/4/2008 2:00:00 AM
  Last Editorial Review: 9/4/2008

• New Screening Catches More Breast Cancers

  Posted: September 4th, 2008, 3:00am EDT

  Title: New Screening Catches More Breast Cancers
  Category: Health News
  Created: 9/4/2008 2:00:00 AM
  Last Editorial Review: 9/4/2008

• Drug Given 24 Hours After Stroke Helps Repair Brain Tissue

  Posted: September 4th, 2008, 3:00am EDT

  Title: Drug Given 24 Hours After Stroke Helps Repair Brain Tissue
  Category: Health News
  Created: 9/4/2008 2:00:00 AM
  Last Editorial Review: 9/4/2008

• Being Tall May Raise Prostate Cancer Risk

  Posted: September 4th, 2008, 3:00am EDT

  Title: Being Tall May Raise Prostate Cancer Risk
  Category: Health News
  Created: 9/4/2008
  Last Editorial Review: 9/4/2008

Topix.net - Cancer

• Research shows many women not adhering to breast cancer therapy

  Posted: September 3rd, 2008, 11:09pm EDT

  Advancements in breast cancer treatments mean more Canadian women are surviving breast cancer than ever before.

• Network TV's anchor trio join the cancer fight

  Posted: September 3rd, 2008, 6:42pm EDT

  Katie Couric, Charles Gibson and Brian Williams have something in common besides their jobs: Each has lost loved ones to cancer _ which gives them something in common with nearly everybody.

MSNBC.com: Cancer

• New way to spot breast cancer shows promise

  Posted: September 3rd, 2008, 6:00pm EDT

  A radioactive tracer that "lights up" cancer hiding inside dense breasts showed promise in its first big test against mammograms,  doctors reported Wednesday.

  
  

Medical News Today - Cancer/Oncology News

• Link Between Nationality And Cervical Cancer

  Posted: September 3rd, 2008, 4:00pm EDT

  Gynaecological screening tests for cervical cancer have been available to all women in Sweden for almost four decades. Despite this, many immigrant women have a higher risk of developing the disease than Swedish-born women, according to a new study from the Swedish medical university Karolinska Institutet.

Topix.net - Cancer

• Breast Cancer Drug Not Tied to Cognitive Decline: Study

  Posted: September 3rd, 2008, 2:15pm EDT

  Contrary to previous study results, the cancer prevention drug anastrozole does not appear to cause impairment of cognitive performance, a new study found.

MSNBC.com: Cancer

• Blood calcium tied to lethal prostate cancer

  Posted: September 3rd, 2008, 11:09am EDT

  Men with elevated levels of calcium in their blood may have a much higher risk of getting fatal prostate cancer, U.S. researchers said on Wednesday.

Topix.net - Cancer

• Harsh Prostate Cancer Fixes Can Mean Waiting

  Posted: September 3rd, 2008, 9:54am EDT

  When most patients hear they have cancer, the first question they ask their doctor is, "What are we going to do?" Increasingly with prostate cancer, the answer is, "Nothing," Boston television station WCVB ...

Medical News Today - Breast Cancer News

• IU Simon Cancer Center's Tissue Bank Collecting Samples Sept. 20 At Clarian North

  Posted: September 3rd, 2008, 6:00am EDT

  Would you like to contribute to breast cancer research? You can help by donating a tissue sample to the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center from 9 a.m. to 2 p.m. Saturday, Sept. 20, at Ology Spa at the Clarian North Medical Center, 11700 North Meridian St., Carmel. A tissue sample will be taken from one breast with a needle and local anesthesia. The amount of tissue taken is about one gram (or the size of two peas).

Medical News Today - Cancer/Oncology News

• IU Simon Cancer Center's Tissue Bank Collecting Samples Sept. 20 At Clarian North

  Posted: September 3rd, 2008, 6:00am EDT

  Would you like to contribute to breast cancer research? You can help by donating a tissue sample to the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center from 9 a.m. to 2 p.m. Saturday, Sept. 20, at Ology Spa at the Clarian North Medical Center, 11700 North Meridian St., Carmel. A tissue sample will be taken from one breast with a needle and local anesthesia. The amount of tissue taken is about one gram (or the size of two peas).

• Brain Cancer Patients Treated Using Fast And Efficient RapidArc Radiotherapy Technology From Varian Medical Systems

  Posted: September 3rd, 2008, 6:00am EDT

  Two leading cancer centers have carried out groundbreaking radiosurgery treatments for multiple brain metastases using new RapidArc radiotherapy technology from Varian Medical Systems (NYSE:VAR). The MIMA Cancer Center in Melbourne, Florida and VU University Medical Center in Amsterdam, Netherlands were each able to treat brain metastases more quickly and efficiently than would have previously been possible.

• Moffitt Cancer Center Receives Prestigious SPORE Grant Worth More Than $10 Million

  Posted: September 3rd, 2008, 6:00am EDT

  The National Cancer Institute (NCI) has awarded Dr. Gerold Bepler , program leader for thoracic oncology at

• Rates Of Oesophageal Cancer In UK Among The Worst In Europe

  Posted: September 3rd, 2008, 6:00am EDT

  Call for national research study to investigate the causes of oesophageal cancer The Barrett's Oesophagus Foundation would like to support the Chief Medical Officer's recommendation for a large scale national research study to investigate the risk factors associated with the rising rate of cancer of the oesophagus. This was included in his Annual Report published yesterday, which raised grave concern over the sharp rise in oesophageal (gullet) cancer over the last two decades.

• How Research Is Tackling Cancer: Free Public Lecture In Newcastle

  Posted: September 3rd, 2008, 5:00am EDT

  Cancer touches many people, but few have the chance to meet the researchers who have dedicated their lives to tackling the disease. This month two world renowned cancer researchers will give a free public lecture in Newcastle to explain how their research is contributing to a better understanding of cancer and more effective treatments.

• 'Tanorexia' Common Among University Students According To Survey

  Posted: September 3rd, 2008, 5:00am EDT

  A new study conducted at a large university finds more than 25 percent of those surveyed reported symptoms of tanning dependence, including symptoms similar to alcohol and drug-addicted individuals. Suggestively, the study also found those with a tanning dependence tend to be more likely to be thin and smoke cigarettes than others. The study by researchers at Fox Chase Cancer Center is published in the September/October issue of the American Journal of Health Behavior.

• Ezetimibe And Cancer Link Still Not Clear Say Experts

  Posted: September 3rd, 2008, 5:00am EDT

  The link between cholesterol-lowering drug ezetimibe (marketed as Vytorin) and cancer is still not clear, wrote the editors of the leading medical journal New England Journal of Medicine (NEJM). More time is needed to assess the drug, they said, and in the meantime patients and doctors will have to live with the uncertainty.

Topix.net - Cancer

• Height Linked to Risk of Prostate Cancer Development and Progression

  Posted: September 3rd, 2008, 4:14am EDT

  A man's height is a modest marker for risk of prostate cancer development, but is more strongly linked to progression of the cancer, say British researchers who conducted their own study on the connection and ...

Medical News Today - Cancer/Oncology News

• ProsCan For Men: Randomised Controlled Trial Of A Decision Support Intervention For Men With Localised Prostate Cancer

  Posted: September 3rd, 2008, 4:00am EDT

  UroToday.com - With advances in treatment for prostate cancer and the often deleterious side-effects of treatment, newly diagnosed men are faced with difficult treatment decisions. For men with localised disease, the complexity of treatment decision-making is enhanced by the notion that some tumours are indolent in nature and therefore unlikely to ever cause clinical concern or death if left untreated.

• Potential To Prevent Recurrence Of Bladder Tumors After Surgical Removal Of Upper Urinary Tract Transitional Cell Carcinoma

  Posted: September 3rd, 2008, 4:00am EDT

  UroToday.com - In this article from the International Journal of Urology, the authors evaluated the survival benefit and prevention of bladder cancer recurrence with adjuvant platinum based chemotherapy, in upper urinary tract urothelial cancer, following surgical resection. Between April 1986 and August 2005, 132 patients with upper urinary tract urothelial cancer underwent radical nephroureterectomy with bladder cuff.

• U.S. Phase 2 Combination Clinical Trial For Non-Small Cell Lung Cancer Patients With K-RAS Or EGFR-Activated Tumours

  Posted: September 3rd, 2008, 4:00am EDT

  Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced that following U.S. Food and Drug Administration (FDA) review, the Company is initiating a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumours. The Principal Investigator is Dr.

• Debiopharm And EPFL Sign Research Project Agreement To Identify Inhibitors Of Signalling Pathways Controlling Cell Fate For Cancer Treatment

  Posted: September 3rd, 2008, 3:00am EDT

  Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist focusing on serious medical conditions and particularly oncology, announced the signature of a research project with the Ecole Polytechnique Federale de Lausanne (EPFL), aimed at the identification of novel small molecules and peptides that interfere with pathways controlling cell fate specification.

• New Discovery About Growth Factor Can Be Breakthrough For Cancer Research

  Posted: September 3rd, 2008, 3:00am EDT

  A research team at the Ludwig Institute and Uppsala University has discovered an entirely new signal path for a growth factor that is of crucial importance for the survival and growth of cancer cells. This discovery, published in today's issue of Nature Cell Biology, opens up an entirely new landscape for research on breast and prostate cancer, among other types. Our cells' ability to understand signals from various growth factors is critical for normal fetal development.